✦ LIBER ✦

Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP* experience

✍ Scribed by Fiorina Giona; Anna Maria Testi; Luciana Annino; Sergio Amadori; William Arcese; Andrea Camera; Luca Cordero Di Montezemolo; Saverio Ladogana; Vincenzo Liso; Giovanna Meloni; Maria Luisa Moleti; Roberto Rondelli; Luigi Zanesco; Andrea Pession; Franco Mandelli

Book ID: 114713488
Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 541 KB
Volume: 86
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1994.tb03252.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early UK experience in the use of clofar

Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia

✍ David O’Connor; Keith Sibson; Mark Caswell; Philip Connor; Michelle Cummins; Chr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

The feasibility of using topotecan, vino

The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma

✍ Hiwarkar, P; Arkenau, H-T; Treleaven, J; Morgan, G; Potter, M; Ethell, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

l-asparaginase loaded red blood cells in

l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial

✍ Carine Domenech; Xavier Thomas; Sylvie Chabaud; Andre Baruchel; François Gueyffi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Clofarabine and high-dose cytosine arabi

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 98 KB

Clofarabine (40 mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

Changes in the oral health of children d

Changes in the oral health of children during treatment for acute lymphoblastic leukaemia

✍ ELIZABETH A. O'SULLIVAN; Dr. MONTY S. DUGGAL; C.C. BAILEY 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Acute lymphoblastic leukemia and Down sy

Acute lymphoblastic leukemia and Down syndrome : Presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

✍ Maurizio Arico; Ottavio Ziino; Maria Grazia Valsecchi; Giovanni Cazzaniga; Carlo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB